The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen
Open accessAbstract
BACKGROUND: Breast cancer chemotherapy commonly causes premature ovarian failure and infertility. Because increased estrogen levels are thought to be potentially risky in breast cancer patients, natural cycle IVF (NCIVF) has been used to preserve fertility and treat infertility in these women. METHODS: Twelve women with breast cancer received 40-60 mg tamoxifen for 6.9 +/- 0.6 days beginning on days 2-3 of their menstrual cycle (15 cycles), and had IVF (TamIVF) with either fresh embryo transfer (six cycles) or cryopreservation (nine cycles). They were compared to a retrospective control group (n = 5) who had natural cycle IVF (NCIVF, nine cycles). RESULTS: Cycle cancellation was significantly less frequent in TamIVF, compared with NCIVF (1/15 versus 4/9, P < 0.05). Compared with NCIVF, TamIVF patients had a greater number of mature oocytes (1.6 +/- 0.3 versus 0.7 +/- 0.2, P = 0.03) and embryos (1.6 +/- 0.3 versus 0.6 +/- 0.2, P = 0.02) per initiated cycle. TamIVF resulted in the generation of embryo(s) in every patient (12/12) while only three out of five patients had an embryo following NCIVF. Two out of six patients in TamIVF, and 2/5 in NCIVF conceived. One patient in the TamIVF group delivered a set of twins. After a mean follow up of 15 +/- 3.6 months (range 3-54), none of the patients had a recurrence of cancer. CONCLUSIONS: Tamoxifen stimulation appears to result in a higher number of embryos and may provide a safe method of IVF and fertility preservation in breast cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE JOURNAL OF REPRODUCTIVE MEDICINE: PATIENT ANXIETY DURING GYNECOLOGIC EXAMINATIONS
Reddy, D. M., & Wasserman, S. A. (1999) · American Journal of Nursing · doi:10.1097/00000446-199901000-00024 · Cited by 2,483
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
Acta Obstetricia et Gynecologica Scandinavica
(2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/(issn)1600-0412 · Cited by 1,174
Early Breast Cancer Trialists’ Collaborative Group, & Peto, R. (1993) · Recent Results in Cancer Research · doi:10.1007/978-3-642-84745-5_21 · Cited by 958
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
Bines, J., Oleske, D. M., & Cobleigh, M. A. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1718 · Cited by 816
Risk of Menopause During the First Year After Breast Cancer Diagnosis
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M., & Hood, N. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2365 · Cited by 606
Ovarian Function after Transplantation of Frozen, Banked Autologous Ovarian Tissue
Oktay, K., & Karlikaya, G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422516 · Cited by 567
Self-citationReproduction post-chemotherapy in young cancer patients
Meirow, D. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00365-8 · Cited by 381
Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata
Jordan, V. C. (1976) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(76)90030-x · Cited by 371
Oktay, K. (2001) · JAMA · doi:10.1001/jama.286.12.1490 · Cited by 354
Self-citationFisher, S. A., Reid, R. L., Van Vugt, D. A., & Casper, R. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03241-7 · Cited by 347 · cited 1×
“Nevertheless, aromatase inhibitor drugs have recently been used in ovulation induction (Fisher et al., 2002), and we are conducting a prospective study to test their value for fertility preservation in breast cancer patients as they may not result in a rise in estradiol levels.”
BackgroundHARPER, M. J. K., & WALPOLE, A. L. (1966) · Nature · doi:10.1038/212087a0 · Cited by 327
Allred, C. D., Allred, K. F., Ju, Y. H., Virant, S. M., & Helferich, W. G. (2001) · PubMed · Cited by 326
Klijn, J. G. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.903 · Cited by 248
Meirow, D., Epstein, M., Lewis, H., Nugent, D., & Gosden, R. G. (2001) · Human Reproduction · doi:10.1093/humrep/16.4.632 · Cited by 229
Tamoxifen treatment and gynecologic side effects: a review
MOURITS, M. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)01196-0 · Cited by 200
The estrogen‐regulated protein, TFF1, stimulates migration of human breast cancer cells
Prest, S. J., May, F. E. B., & Westley, B. R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0498fje · Cited by 188
Palermo, G. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540230043033 · Cited by 161
Trends in breast cancer in younger women in contrast to older women.
Hankey, B. F., Miller, B., Curtis, R., & Kosary, C. L. (1994) · PubMed · Cited by 137
New Synthetic Agent for the Induction of Ovulation: Preliminary Trials in Women
Klopper, A. I., & Hall, M. (1971) · BMJ · doi:10.1136/bmj.1.5741.152 · Cited by 129
Goldenhar's Syndrome Associated With Tamoxifen Given to the Mother During Gestation
Cullins, S. L. (1994) · JAMA · doi:10.1001/jama.1994.03510480029019 · Cited by 118
Boostanfar, R., Jain, J. K., Mishell, D. R., & Paulson, R. J. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01749-6 · Cited by 97
Massai, M. R., de Ziegler, D., Lesobre, V., Bergeron, C., Frydman, R., & Bouchard, P. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55973-1 · Cited by 77
Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility
Omland, A. K., Fedorcsák, P., Storeng, R., Dale, P. O., Åbyholm, T., & Tanbo, T. G. (2001) · Human Reproduction · doi:10.1093/humrep/16.12.2587 · Cited by 59
Halakivi-Clarke, L., Cho, E., Onojafe, I. F., et al. (2000) · PubMed · Cited by 58
Induction of luteal phase defect with clomiphene citrate
Cook, C. L., Schroeder, J. A., Yussman, M. A., & Sanfilippo, J. S. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90244-8 · Cited by 58
Comparison between tamoxifen and clomiphene for induction of ovulation.
Messinis, I. E., & Nillius, S. J. (1982) · PubMed · Cited by 49
Comparison between tamoxifen and clomiphene therapy in women with anovulation
Gerhard, I., & Runnebaum, B. (1979) · Archives of Gynecology and Obstetrics · doi:10.1007/bf02109916 · Cited by 42
The potential of ovarian tissue transplant to preserve fertility
Büyük, E., & Oktay, K. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.4.361 · Cited by 32
Self-citationSadek, S., & Bell, S. C. (1996) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1996.tb09830.x · Cited by 28
Chemical inducers of ovulation: comparative results.
Ruiz-Velasco, V., Rosas-Arceo, J., & Mm, M. (1979) · PubMed · Cited by 28
Suginami, H., Kitagawa, H., Nakahashi, N., Yano, K., & Matsubara, K. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55913-5 · Cited by 24
Management of anovulatory infertility
Crosignani, P. G., Bianchedi, D., Riccaboni, A., & Vegetti, W. (1999) · Human Reproduction · doi:10.1093/humrep/14.suppl_1.108 · Cited by 17
Further Observations on the Induction of Ovulation with Clomiphene
Charles, D., LORAINE, J. A., Bell, E. T., & HARKNESS, R. A. (1966) · Fertility and Sterility · doi:10.1016/s0015-0282(16)35946-5 · Cited by 10
Cited by
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Macklon, N. S., Stouffer, R. L., Giudice, L. C., & Fauser, B. C. J. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0015 · Cited by 562
Oktay, K., Buyuk, E., Libertella, N., Akar, M., & Rosenwaks, Z. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.037 · Cited by 528
Self-citationFertility preservation in female patients
Sonmezer, M. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh021 · Cited by 496
Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles
Adhikari, D., & Liu, K. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0048 · Cited by 481
Oktay, K., Hourvitz, A., Sahin, G., Oktem, O., Safro, B., Cil, A., & Bang, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0962 · Cited by 421
Self-citation
Metadata
- Authors
- Oktay, K., Buyuk, E., Davis, O., Yermakova, I., Veeck, L., & Rosenwaks, Z.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-01
- Volume
- 18
- Issue
- 1
- Pages
- 90-95
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2146519887
- Cited by
- 270
- References
- 36
- FWCI
- 18.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.